Verified Document

Pharmacogenetics And Pharmacoeconomics Exploration Diabetes

Pharmacogenetics and Pharmacoeconomics Exploration Introduction

It is important to note, from the onset, that according to the Centers for Disease Control and Prevention – CDC (2018), it is estimated that in the U.S., 30.3 million people have been diagnosed with diabetes thus far. As CDC further points out, within the last two decades, the number of persons diagnosed with the condition has increased by a multiple of 3. This is a clear indicator of the existing need for interventions seeking to salvage the situation. In the long-term, the treatment as well as management of diabetes also happens to be rather costly. According to the American Diabetes Association – ADA (2018), “the estimated total economic cost of diagnosed diabetes in 2017 was $327 billion.” Each year, there are approximately 1.5 million new diagnoses made for diabetes. This text seeks to explore pharmacogenetics and pharmacoeconomics principles in relation to pharmacological treatment as well as patient outcomes. In so doing, the management of type 2 diabetes will be the primary focus. This is more so the case given that type 2 diabetes accounts for a vast majority of diabetes cases.

Discussion

Diabetes presents a staggering economic as well as social burden. As a matter of fact, in 2018, diabetes was listed as a leading cause of death – with the condition assuming the 7th position in this case (CDC, 2018). Further, it is important to note that as Cohen (2010) observes, in the year 2017, the condition used up a total of $245 billion in direct and direct costs. As various research studies conducted in the past have indicated, comorbid conditions usually get in the way of the effective treatment and management of diabetes. Some of the more common comorbid conditions include, but they are not limited to, coronary artery disease, hypertension, and hyperlipidemia. It should be noted that failure to effectively manage...

For instance, given that cardiovascular disease has been linked to a high number of deaths amongst persons with diabetes, the management of the former could lead to better outcomes for the latter. As Cohen (2010) points out, outcomes could also be worsened by a wide range of other factors. For instance, depression could result in poor-self management and failure to properly adhere to the treatment regimen. It therefore follows that the quality of life and glycemic outcomes can in this case be enhanced via the effective management of the comorbid conditions. The economic burden would also be reduced as a consequence.
Antidiabetic pharmaceutical choices are routinely impacted upon by a wide range of global trends. These could be inclusive of “increasing numbers of patients with diabetes, with increasing costs of caring for people with diabetes, and an ever-present focus on the costs of pharmaceuticals…” (Rascati, 2013, p. 201). It is important to note that the authors further observe, the said costs are largely expected to increase going forward as the growing incidence of diabetes mirrors new medications development pace. Pharmacoeconomics permits the application of health economics methodologies as well as principles in diverse pharmaceutical settings. For this reason, the main focus in this case is the assessment and evaluation of the incremental benefits of intervention vis-à-vis the associated costs. .

According to Cohen (2010), “pharmacogenetics and pharmacogenomics investigate the influence of genetic and genomic variations on drug response in individuals” (73). Pharmacogenomics, on the other hand, seeks to assess and evaluate medication responses and the inherent genetic mediators. As far as pharmacogenomics is concerned, studies conducted in the past…

Sources used in this document:

References

American Diabetes Association – ADA (2018). Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care, 41(5), 917-928.

Cohen, N. (2010). Pharmacogenomics and Personalized Medicine. New York, NY: Humana Press.

Centers for Disease Control and Prevention – CDC (2019). About Diabetes. Retrieved from https://www.cdc.gov/diabetes/basics/diabetes.html

Lecka-Czernik, B & Fowlkes, J.L. (Eds.). (2015). Diabetic Bone Disease: Basic and Translational Research and Clinical Applications. Belmont, CA: Springer

Rascati, K. (2013). Essentials of Pharmacoeconomics (2nd ed.). New York, NY: Lippincott Williams & Wilkins.


Cite this Document:
Copy Bibliography Citation

Related Documents

Diabetes Evidence-Based Practice Diabetes Is a Disease
Words: 4125 Length: 13 Document Type: Essay

Diabetes Evidence-Based Practice Diabetes Diabetes is a disease which stays with the patient life-long except in some cases where the diabetes is gestational which occurs during pregnancy and often goes back to normal after the delivery. Typically there are two types of diabetes which are type 1 and type 2 diabetes but less common are gestational diabetes and other types which contain features of both type 1 and type 2 diabetes (Cowle

Diabetes Mellitus According to the World Diabetes
Words: 998 Length: 3 Document Type: Research Paper

Diabetes Mellitus According to the World Diabetes Foundation, diabetes mellitus is considered to be the fastest growing chronic condition in the world (Chorbev et al., 2011). The diabetes epidemic afflicted an estimated 285 million people in 2010, equivalent to 6.4% of the adult population of the world. Since diabetes is largely a preventable condition, public health efforts must be directed at primary care centered on awareness and education regarding, causes, risk

Diabetes Management Diabetes Mellitus Is One of
Words: 2575 Length: 10 Document Type: Essay

Diabetes Management Diabetes mellitus is one of the non-communicable diseases that have continued to be in the forefront of public health challenges. Diabetes occurs when the body system is unable to produce sufficient insulin. Typically, insulin is a hormone secreted from the beta cell within the pancreases that regulates the blood sugar as well as assisting in conversion of glucose into energy. Diabetes occurs when there is high level of glucose

Diabetes in Australia the Australian Government and
Words: 2674 Length: 8 Document Type: Essay

Diabetes in Australia The Australian government and the relevant Health agencies have for many years strived to put the diabetes menace under close observation and management. There have been massive researches and huge sums directed towards good management and possible elimination of diabetes at the national levels. This commitment is exhibited by the specialized funds and efforts like the Juvenile Diabetes Research Fund (JDRF) that has been committed to striving to

Diabetes: The Future of a Chronic Disease
Words: 1056 Length: 3 Document Type: Research Paper

Diabetes: The future of a chronic disease The number of cases of type II diabetes has seen a dramatic increase in recent years, both in the United States and worldwide. The primary reasons for this increase are generally attributed to increased consumption of high-sugar, high-starch, and highly caloric food and a lack of exercise. The International Diabetes Foundation estimates that "one in 10 of the world's population will have diabetes by

Diabetes Mellitus Is a Disease
Words: 990 Length: 3 Document Type: Research Paper

As blood flows, it starts attracting the fluid from the tissues and therefore more fluid is entering the kidneys when filtering the blood, causing an increase in urination. And because the body is losing so much fluid, dry mouth and an increase in thirst are initiated (Martini, Nath, & Bartholomew, 2011). Other symptoms include fatigue, blurred vision, and sudden loss of weight (American Diabetes Association, 2013). These symptoms are

Sign Up for Unlimited Study Help

Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.

Get Started Now